Wells Fargo’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-805,912
| Closed | -$282K | – | 6301 |
|
|
2018
Q2 | $282K | Sell |
805,912
-212,819
| -21% | -$74.5K | ﹤0.01% | 4697 |
|
|
2018
Q1 | $1.53M | Buy |
1,018,731
+331,800
| +48% | +$498K | ﹤0.01% | 3546 |
|
|
2017
Q4 | $975K | Buy |
686,931
+413,801
| +152% | +$587K | ﹤0.01% | 3884 |
|
|
2017
Q3 | $625K | Buy |
273,130
+113,720
| +71% | +$260K | ﹤0.01% | 4098 |
|
|
2017
Q2 | $215K | Sell |
159,410
-53,600
| -25% | -$72.3K | ﹤0.01% | 4584 |
|
|
2017
Q1 | $456K | Sell |
213,010
-95,738
| -31% | -$205K | ﹤0.01% | 4203 |
|
|
2016
Q4 | $1.36M | Buy |
308,748
+47,979
| +18% | +$212K | ﹤0.01% | 3417 |
|
|
2016
Q3 | $1.27M | Buy |
260,769
+22,441
| +9% | +$109K | ﹤0.01% | 3258 |
|
|
2016
Q2 | $786K | Buy |
238,328
+54,858
| +30% | +$181K | ﹤0.01% | 3573 |
|
|
2016
Q1 | $652K | Buy |
+183,470
| New | +$652K | ﹤0.01% | 3629 |
|